1.Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore.
Phong Ching LEE ; Kwang Wei THAM ; Hong Chang TAN ; Shanker PASUPATHY
Singapore medical journal 2013;54(7):382-386
INTRODUCTIONObesity is a risk factor for type 2 diabetes mellitus (T2DM). Metabolic-bariatric surgery (MBS) results in significant weight loss with dramatic improvement in T2DM. This study analysed the effects of MBS on patients with T2DM in a tertiary centre in Singapore.
METHODSIndividuals with T2DM who underwent MBS in a single centre from September 2008 to May 2012, with at least 12 months of regular follow-up, were included in our study. The primary outcome measure was good glycaemic control (glycated haemoglobin [HbA1c] < 6.5%, with or without medications) 12 months after surgery. Secondary outcome measures were partial DM remission (fasting blood glucose [FBG] < 7.0 mmol/L and HbA1c < 6.5% without DM medications), complete DM remission (FBG < 5.6 mmol/L and HbA1c < 6.0% without DM medications), weight, body mass index, blood pressure, and fasting serum lipid, serum glucose and serum insulin levels.
RESULTSOf the 19 patients who met the inclusion criteria, 14 underwent gastric bypass and 5 underwent sleeve gastrectomy. At 12 months postoperatively, 17 (89.5%) patients achieved good glycaemic control. DM remission was achieved in 14 (73.7%) patients, with 10 (52.6%) attaining complete remission.
CONCLUSIONIn Singapore, MBS is an effective treatment modality for obese patients with T2DM. Despite the small sample size and lack of matched controls, the present study suggests that MBS is effective in achieving significant weight loss and eliciting a significant and sustainable improvement in the glycaemic control of patients with T2DM, for up to 12 months.
Adult ; Bariatric Surgery ; Blood Glucose ; analysis ; Body Mass Index ; Diabetes Mellitus, Type 2 ; prevention & control ; Female ; Glycated Hemoglobin A ; analysis ; Humans ; Insulin ; blood ; Lipids ; blood ; Male ; Middle Aged ; Obesity, Morbid ; surgery ; Prospective Studies ; Risk Factors ; Singapore ; Treatment Outcome
2.Current treatment landscape for obesity in Singapore.
Phong Ching LEE ; Chin Hong LIM ; Ravishankar ASOKKUMAR ; Marvin Wei Jie CHUA
Singapore medical journal 2023;64(3):172-181
The rising prevalence of obesity in Singapore is a harbinger for a corresponding increase in obesity-related complications such as type 2 diabetes mellitus (T2DM) and coronary heart disease. Obesity is a complex disease driven by multiple factors, and hence, treatment cannot follow a 'one-size-fits-all' approach. Lifestyle modifications involving dietary interventions, physical activity and behavioural changes remain the cornerstone of obesity management. However, similar to other chronic diseases such as T2DM and hypertension, lifestyle modifications are often insufficient on their own, hence the importance of other treatment modalities including pharmacotherapy, endoscopic bariatric therapy and metabolic-bariatric surgery. Weight loss medications currently approved in Singapore include phentermine, orlistat, liraglutide and naltrexone-bupropion. In recent years, endoscopic bariatric therapies have evolved as an effective, minimally invasive and durable therapeutic option for obesity. Metabolic-bariatric surgery remains the most effective and durable treatment for patients with severe obesity, with an average weight loss of 25%-30% after one year.
Humans
;
Singapore
;
Diabetes Mellitus, Type 2
;
Obesity
;
Obesity, Morbid
;
Bariatric Surgery
3.Effectiveness of bariatric surgery in diabetes prevention in high-risk Asian individuals.
Phong Ching LEE ; Hong Chang TAN ; Shanker PASUPATHY ; Sonali GANGULY ; Alvin Kim Hock ENG ; Nivedita NADKARNI ; Kwang Wei THAM
Singapore medical journal 2018;59(9):472-475
INTRODUCTIONObesity is a key risk factor in the development of Type 2 diabetes mellitus (T2DM). Bariatric surgery causes a large amount of durable weight loss in those with clinically severe obesity. We reported the effect of weight loss via bariatric surgery on DM prevention in those at high risk of developing DM.
METHODSThis was a retrospective cohort study of 44 patients with obesity (mean body mass index 43.8 kg/m) and pre-DM who underwent bariatric surgery and were followed up for up to three years. We also reviewed a non-surgical cohort of patients with obesity and pre-DM seen at the weight management clinic.
RESULTS91% of patients attained normal glycaemic status at one year after bariatric surgery. At the three-year follow-up, 87.5% of the patients maintained normoglycaemia. None of the patients developed T2DM after surgery. 26.9% of patients achieved absolute weight loss at one year after bariatric surgery and maintained this at two and three years post surgery (p < 0.001 vs. baseline). The homeostatic model assessment-insulin resistance index in patients also decreased from 5.50 at baseline to 1.20, 1.14 and 1.44 at one, two and three years, respectively (p < 0.001).
CONCLUSIONBariatric surgery produces significant weight loss, and leads to reversion from the pre-diabetic state to normal glycaemic status and reduction of the incident DM rate in those with pre-DM and morbid obesity.